Robert I. Grossman, MD
Dean and Chief Executive Officer
Since 2007, Robert I. Grossman, MD, has been chief executive officer of NYU Langone Health and dean of NYU School of Medicine, which was renamed in his honor in 2019 as NYU Grossman School of Medicine. In this role, he oversees more than 45,000 employees, students, and noncompensated faculty across 6 inpatient locations and over 320 sites throughout the New York region and in Florida. In 2019, NYU Langone completed a full-asset merger with Winthrop-University Hospital, now known as NYU Langone Hospital—Long Island, one of Long Island’s top medical centers. Most recently, NYU Langone affiliated with Long Island Community Hospital, creating a clinically integrated healthcare network between the two organizations. Also part of NYU Langone are Perlmutter Cancer Center, a National Cancer Institute–designated comprehensive cancer center, and NYU Grossman School of Medicine, which since 1841 has trained thousands of physicians and scientists who have helped to shape the course of medical history.
In collaboration with the Board of Trustees and institutional leadership, Dr. Grossman increased NYU Langone’s revenue from $2 billion in 2007 to $10.2 billion in 2021, and more than $3.9 billion in philanthropy has also been raised. Also of note, NYU Langone’s National Institutes of Health (NIH) 2021 research awards totaled $815 million—an increase of more than 532 percent compared to 2007.
Early in his tenure, Dr. Grossman launched a major campus transformation that resulted in the addition of more than 13 million square feet of clinical, educational, and research space across campuses in Manhattan, Brooklyn, and Long Island. Of note was the opening of a new Science Building, Kimmel Pavilion, and Hassenfeld Children’s Hospital at NYU Langone.
As dean of NYU Grossman School of Medicine, Dr. Grossman led the historic and unprecedented initiative of providing tuition-free medical education for all current and future students in its MD degree program. He also curated a new approach to medical education, called Curriculum for the 21st Century (C21), which emphasizes clinical training from the beginning of medical school and includes a revolutionary three-year MD program for select candidates. Most recently Dr. Grossman was the driving force behind the creation of NYU Long Island School of Medicine—a partnership between NYU and NYU Langone Health—offering full-tuition scholarships with an accelerated three-year curriculum exclusively devoted to training primary care physicians.
Each year, NYU Langone Health and NYU Grossman School of Medicine are recognized by outside accreditation entities for providing outstanding care, including U.S. News & World Report’s “Top Hospitals” and “Best Graduate Schools;” the Center for Medicare and Medicaid Services; the Leapfrog Group; Vizient, Inc.; and more.
In 2018, Dr. Grossman was named to Time magazine’s inaugural Health Care 50 list of the 50 most influential healthcare leaders who changed the state of healthcare in America, together with Ken Langone, chairman of NYU Langone’s Board of Trustees. Additionally, he was named a “Living Landmark” by the New York Landmarks Conservancy in 2013 for his leadership in the aftermath of Hurricane Sandy, which caused unprecedented damage to NYU Langone’s facilities and required the safe evacuation of 322 patients. Recently, Dr. Grossman’s pivotal leadership at NYU Langone was chronicled in William A. Haseltine’s book World Class: A Story of Adversity, Transformation, and Success at NYU Langone Health.
A prolific and highly respected scientist, Dr. Grossman was awarded the Javits Neuroscience Investigator Award by the NIH in 1999 for his work on multiple sclerosis. He was a member (1995–2000) and chairman (1997–2000) of the Diagnostic Radiology Study Section at the NIH, was appointed to the NIH’s National Advisory Council for Biomedical Imaging and Bioengineering (2003–2007), and, in 2004, became the first recipient of the Outstanding Contributions in Research Award, given annually by the Foundation of the American Society of Neuroradiology in recognition of lifelong accomplishment and consistent excellence in clinical neuroscience.
In 2010, he received the International Society for Magnetic Resonance in Medicine’s (ISMRM’s) Gold Medal for his pioneering research in magnetic resonance in medicine and biology. In addition, he received the Lifetime Achievement of the Emeritus Class from Tulane University (2019), was named a Distinguished Graduate of the University of Pennsylvania School of Medicine (2010), and was awarded an honorary doctorate from the University of Bordeaux, France (2010). Most recently, he received the American Society of Neuroradiology (ASNR) Gold Medal for his contributions to the field of neuroradiology (2021), and was elected to the American Academy of Arts and Sciences (AAAS) for excellence and leadership (2022).
Dr. Grossman is a passionate educator and widely published scholar. He has trained more than 100 fellows, many of whom occupy prominent positions worldwide, and has authored 339 publications and 5 books, including Neuroradiology: The Requisites.
Dr. Grossman received his BS in biology from Tulane University and his MD from the University of Pennsylvania, where he was elected to Alpha Omega Alpha. He completed his internship at Beth Israel Hospital in Boston, two years of a neurosurgery residency at the University of Pennsylvania, a radiology residency at the University of Pennsylvania, and a two-year fellowship in neuroradiology at Massachusetts General Hospital. Dr. Grossman is board certified in radiology and neuroradiology.
Dr. Grossman joined NYU Langone in 2001 as the Louis Marx Professor of Radiology, chairman of the Department of Radiology, and professor of neurology, neurosurgery, and physiology and neuroscience. In his previous position at the Hospital of the University of Pennsylvania, he was a professor of radiology, neurosurgery, and neurology; chief of neuroradiology; and associate chairman of radiology.